Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Capital Leases (2016 - 2018)

Wave Life Sciences (WVE) has disclosed Capital Leases for 4 consecutive years, with $9.2 million as the latest value for Q4 2018.

  • For Q4 2018, Capital Leases rose 198.87% year-over-year to $9.2 million; the TTM value through Dec 2018 reached $9.2 million, up 198.87%, while the annual FY2018 figure was $9.2 million, 198.87% up from the prior year.
  • Capital Leases hit $9.2 million in Q4 2018 for Wave Life Sciences, up from $8.2 million in the prior quarter.
  • Across five years, Capital Leases topped out at $9.2 million in Q4 2018 and bottomed at $16000.0 in Q4 2016.
  • Average Capital Leases over 4 years is $2.6 million, with a median of $1.6 million recorded in 2017.
  • Year-over-year, Capital Leases plummeted 79.49% in 2016 and then surged 19237.5% in 2017.
  • Wave Life Sciences' Capital Leases stood at $78000.0 in 2015, then tumbled by 79.49% to $16000.0 in 2016, then soared by 19237.5% to $3.1 million in 2017, then surged by 198.87% to $9.2 million in 2018.
  • According to Business Quant data, Capital Leases over the past three periods came in at $9.2 million, $8.2 million, and $6.5 million for Q4 2018, Q3 2018, and Q2 2018 respectively.